Neurobrosin 60mg Injection contains active components called Cerebroprotein hydrolysate. This medication has been considered as a potential treatment for various forms of dementia, including Alzheimer's disease (progressive memory loss and cognitive decline) and vascular dementia. It has been investigated as a possible therapeutic option for certain neurodegenerative conditions, such as Parkinson's disease (neurodegenerative disorder with tremors, stiffness, and impaired movement) and Huntington's disease (a hereditary condition causing involuntary movements and cognitive decline.). In some cases, it has been used to manage cognitive impairments, including those associated with aging and other neurological disorders. Individuals with known allergies or hypersensitivity to any components of Cerebroprotein hydrolysate should avoid its use. Individuals with acute or severe medical conditions, especially those affecting the brain or central nervous system, should avoid this medication. As it can potentially modulate the immune system, individuals with autoimmune disorders may be at risk of exacerbating their condition so its use should be avoided. The safety and efficacy of this medication in children have not been extensively studied, so its use in pediatric populations may not be recommended.  Always consult a healthcare professional before using it in old age.